Literature DB >> 16518627

Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type.

Tarak Srivastava1, Robert E Garola, Marjo Kestila, Karl Tryggvason, Vesa Ruotsalainen, Mukut Sharma, Virginia J Savin, Hannu Jalanko, Bradley A Warady.   

Abstract

We report a Caucasian boy of Italian descent with congenital nephrotic syndrome of the Finnish type (NPHS1, CNF, MIM 256300) who developed recurrence of proteinuria and hypoalbuminemia on the seventh post-operative day following living related renal transplantation from his paternal aunt. The allograft biopsy was normal except for effacement of podocyte foot processes on electron microscopy. He was treated by the substitution of mycophenolate mofetil with cyclophosphamide for 12 weeks, in addition to cyclosporine, prednisone and daclizumab. His proteinuria resolved quickly following the initiation of cyclophosphamide treatment, and he remains in remission 4 years after receiving his transplant. His native and allograft kidneys were evaluated for nephrin expression by immunohistochemistry, DNA analysis for the NPHS1 mutation, serum for the presence of auto-antibodies to nephrin by both enzyme-linked immunosorbent assay (ELISA) and fetal glomeruli immunofluorescence assay, and serum for glomerular permeability to albumin (Palb) activity using a functional in vitro assay for Palb. Nephrin expression was completely absent in the native kidney, while it was decreased in the allograft compared with normal. DNA analysis of the NPHS1 gene revealed mutations 3248G>T and 3250delG in exon 24, causing G1083V and 1084Vfs, respectively, inherited from his father, and 3478C>T in exon 27, that leads to R1160X, inherited from his mother. Serum was negative for auto-antibodies to nephrin. Interestingly, the Palb activity was increased at the time of recurrence of proteinuria following transplantation (Palb 0.73+/-0.10) and remained elevated when retested more than 3 years later (Palb 0.54+/-0.09). This is the first report of increased Palb activity in recurrence of proteinuria following transplantation in NPHS1. We speculate the role of increased Palb activity in the recurrence of proteinuria following transplantation in NPHS1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518627     DOI: 10.1007/s00467-006-0047-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.

Authors:  R Kalluri; A Torre; C F Shield; E D Zamborsky; M C Werner; E Suchin; G Wolf; U M Helmchen; L P van den Heuvel; R Grossman; S Aradhye; E G Neilson
Journal:  Transplantation       Date:  2000-02-27       Impact factor: 4.939

2.  Nitric oxide increases albumin permeability of isolated rat glomeruli via a phosphorylation-dependent mechanism.

Authors:  Bing Li; Jian Yao; Tetsuo Morioka; Takashi Oite
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

3.  Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP.

Authors:  R Sharma; M Sharma; X Ge; E T McCarthy; V J Savin
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

4.  "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma.

Authors:  M Sharma; R Sharma; E T McCarthy; V J Savin
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

5.  Renal transplantation in children under 5 years of age.

Authors:  J A Kari; J Romagnoli; P Duffy; O N Fernando; L Rees; R S Trompeter
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

6.  Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells.

Authors:  R Sharma; H B Lovell; T B Wiegmann; V J Savin
Journal:  J Am Soc Nephrol       Date:  1992-11       Impact factor: 10.121

7.  The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.

Authors:  Mukut Sharma; Ram Sharma; Ellen T McCarthy; Virginia J Savin
Journal:  Exp Biol Med (Maywood)       Date:  2004-01

8.  Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.

Authors:  Michele Carraro; Gianluca Caridi; Maurizio Bruschi; Mary Artero; Roberta Bertelli; Cristina Zennaro; Luca Musante; Giovanni Candiano; Francesco Perfumo; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

9.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome.

Authors:  M Kestilä; U Lenkkeri; M Männikkö; J Lamerdin; P McCready; H Putaala; V Ruotsalainen; T Morita; M Nissinen; R Herva; C E Kashtan; L Peltonen; C Holmberg; A Olsen; K Tryggvason
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

Review 10.  Management of congenital nephrotic syndrome of the Finnish type.

Authors:  C Holmberg; M Antikainen; K Rönnholm; M Ala Houhala; H Jalanko
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

View more
  6 in total

Review 1.  Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.

Authors:  Hernán Trimarchi
Journal:  World J Nephrol       Date:  2013-11-06

2.  Abdominal distention and continuous feeding intolerance after intraperitoneal kidney transplant: Answers.

Authors:  Valeriya M Feygina; Anil Kotru; Christine Du
Journal:  Pediatr Nephrol       Date:  2017-06-06       Impact factor: 3.714

3.  Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.

Authors:  Gabriela Casalena; Stefanie Krick; Ilse Daehn; Liping Yu; Wenjun Ju; Shaolin Shi; Su-yi Tsai; Vivette D'Agati; Maja Lindenmeyer; Clemens D Cohen; Detlef Schlondorff; Erwin P Bottinger
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-05

Review 4.  Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation.

Authors:  Christer Holmberg; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2014-03-29       Impact factor: 3.714

Review 5.  Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Virginia J Savin; Ellen T McCarthy; Mukut Sharma
Journal:  Kidney Res Clin Pract       Date:  2012-10-16

6.  Jianpi Qushi Heluo Formula alleviates renal damages in Passive Hemann nephritis in rats by upregulating Parkin-mediated mitochondrial autophagy.

Authors:  Xin-Hui Wang; Rui Lang; Qin Zeng; Ying Liang; Nan Chen; Zhi-Zhong Ma; Ren-Huan Yu
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.